Year 2006

• Careseng® SG2 has been approved by the Ministry of Health, Republic of Georgia as oncology drug.

• Pegasus Pharmaceuticals Group established a subsidiary in the Republic of Georgia.

• Pegasus Pharmaceuticals Group presented on its technology platforms and the Careseng® series at the National Oncology Center, Tbilisi, capital of the Republic of Georgia, and established a comprehensive partnership with the Center.

• The novel anti-HIV compounds discovered by Pegasus Pharmaceuticals Group were being tested at the Aaron Diamond AIDS Research Center, The Rockefeller University, USA, and have been proven to reverse transcriptase of HIV.

• Health Canada granted site license to Pegasus Pharmaceuticals Group.

• Patent Application No. 200302636-6, "Protopanaxadiol and Protopanaxatriol and Their Use as Anti-cancer Agents" was approved by the Singapore Patent Office with patent no. 96495.

• Shanghai Tian-Bo Biosciences Inc. filed a global PCT patent for "Method, Formulation and Use thereof for Improved Oral Absorption of Pharmaceuticals or Nutrients" (PCT/CN200600718).

• A research paper on "Post-absorption and Metabolism of Multi-compound Drug - a new attempt to modernize traditional Chinese medicine" was published in the Journal of Chinese Integrative Medicine in China (2006, 4 (5) :441-446).